Propranolol contraindications: Difference between revisions
Jump to navigation
Jump to search
Gerald Chi (talk | contribs) mNo edit summary |
Gerald Chi (talk | contribs) mNo edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | |||
{{Propranolol}} | |||
{{CMG}} | {{CMG}} | ||
==Contraindications== | |||
==List of contraindications== | ==List of contraindications== | ||
<br> | <br> | ||
Revision as of 22:15, 9 February 2014
| Propranolol |
|---|
| Inderal LA® FDA Package Insert |
| Indications and Usage |
| Dosage and Administration |
| Contraindications |
| Warnings and Precautions |
| Adverse Reactions |
| Drug Interactions |
| Use in Specific Populations |
| Overdosage |
| Description |
| Clinical Pharmacology |
| Nonclinical Toxicology |
| How Supplied/Storage and Handling |
| Labels and Packages |
| Clinical Trials on Propranolol |
| ClinicalTrials.gov |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Contraindications
List of contraindications
Cardiogenic shock
Sinus bradycardia and greater than first-degree block
Bronchial asthma
Patients with known hypersensitivity to Propranolol hydrochloride
Cardiogenic shock
Sinus bradycardia and greater than first-degree block
Bronchial asthma
Patients with known hypersensitivity to Propranolol hydrochloride
References
Adapted from the FDA Package Insert.